EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice

Nan Wu iD, Chaocheng Wu, Yating Du iD, Zhuhua Chan, Runying Zeng iD

Pharmaceutics · 11.06.2026 · 18 (6) · 725

DOI: 10.3390/pharmaceutics18060725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 11.06.2026. Verfasst von Nan Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Technology Innovation Center for Exploitation of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen …. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Department of Science and Technology, Xiamen Natural Science Foundation, Third Institute of Oceanography.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Neoagarotetraose (NA4), a marine-derived tetrasaccharide, holds promise as an anti-inflammatory and antioxidant agent; however, its oral bioavailability and systemic exposure mechanisms require elucidation.

Methods

This study characterizes the biopharmaceutical profile of NA4 after oral and intravenous administration using a validated near-infrared fluorescence method based on covalent conjugation with Cy7.

Results

Following oral gavage (200 mg/kg), NA4-Cy7 was rapidly absorbed (Tmax: 1.0 h; Cmax: 35.6 mg/L), with prolonged systemic exposure (mean residence time: 13.1 h) and an elimination half-life of 8.9 h. Intravenous administration (25 mg/kg) revealed a low volume of distribution at steady state (Vss: 0.0132 L/kg) and a shorter MRT (4.3 h). Tissue distribution at 24 h showed preferential accumulation in the kidney, liver, and lung, with direct visualization of intact NA4 crossing the intestinal epithelium.

Conclusions

These findings demonstrate that fluorescently labeled NA4-Cy7 can cross the intestinal epithelial barrier and reach systemic circulation, supporting its potential as an orally active agent with organ-specific targeting properties.

Schlagwörter

Stichwörter der Autor:innen

Cy7 labelingneoagarotetraose (NA4)oral absorptionpharmacokineticstissue distribution

Autor:innen und Institutionen

  • Technology Innovation Center for Exploitation of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361005, China.

ORCID-Profile: Nan Wu, Yating Du, Runying Zeng

Förderung

  • Fujian Provincial Department of Science and Technology
  • Xiamen Natural Science Foundation
  • Third Institute of Oceanography
  • Innovation Research and Development Special Funds of the Municipality-province-ministry Co-constructed
  • Science and Technology Planning Project of Fujian Province
  • Foundation of Third Institute of Oceanography SOA

Zitieren

APA

Wu, N., Wu, C., Du, Y., Chan, Z., & Zeng, R. (2026). Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice. Pharmaceutics, 18(6), 725. https://doi.org/10.3390/pharmaceutics18060725

Vancouver

Wu N, Wu C, Du Y, Chan Z, Zeng R. Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice. Pharmaceutics. 2026;18(6):725. doi:10.3390/pharmaceutics18060725

BibTeX
@article{Wu2026,
  author = {Wu, Nan and Wu, Chaocheng and Du, Yating and Chan, Zhuhua and Zeng, Runying},
  title = {Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {725},
  doi = {10.3390/pharmaceutics18060725}
}
Kostenlos starten →